Veronique Roguet-Obry - Publications

Leakage of cabotegravir and rilpivirine in HIV patients receiving long-acting injectable antiretroviral therapy.

Journal: The Journal of antimicrobial chemotherapy

Published: July 31, 2025

Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.

Journal: PloS one

Published: May 04, 2021

Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: July 09, 2020

Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?

Journal: AIDS care

Published: April 14, 2020

Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit.

Journal: European journal of gastroenterology & hepatology

Published: December 19, 2019

Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.

Journal: AIDS (London, England)

Published: November 26, 2019

Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 12, 2019

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort.

Journal: BMC infectious diseases

Published: October 10, 2018

Risk factors associated with overweight and obesity in HIV-infected people: Aging, behavioral factors but not cART in a cross-sectional study.

Journal: Medicine

Published: June 08, 2018

HIV infection and care pathway: From guidelines to clinical practice.

Journal: Medecine et maladies infectieuses

Published: November 24, 2017

Ledipasvir and tenofovir drug interaction in human immunodeficiency virus-hepatitis C virus coinfected patients: Impact on tenofovir trough concentrations and renal safety.

Journal: British journal of clinical pharmacology

Published: June 19, 2017

Impact of tenofovir dose adjustment on both estimated glomerular filtration rate and tenofovir trough concentration.

Journal: Antiviral therapy

Published: February 08, 2017